Optimizing Biosimilar Implementation: A Framework for Access, Adoption, and Sustainability : Episode 1
One Institution’s Evidence-Based Approach to Adopting Biosimilars
A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process that examines clinical data, safety profiles, and cost implications while prioritizing operational efficiency, patient access, and seamless transitions between reference products and biosimilars.
Video content above is prompted by the following:
- Please describe the process your institution uses to review biosimilars as potential additions to the formulary.
- What priorities were identified by your institution for the purposes of operationalizing the use of biosimilars?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
